Market Capitalization (Millions $) |
15 |
Shares
Outstanding (Millions) |
1 |
Employees |
327 |
Revenues (TTM) (Millions $) |
111 |
Net Income (TTM) (Millions $) |
-16 |
Cash Flow (TTM) (Millions $) |
-1 |
Capital Exp. (TTM) (Millions $) |
0 |
Acorda Therapeutics Inc
Acorda Therapeutics Inc is a biopharmaceutical company based in Ardsley, New York, that specializes in the development and commercialization of therapies for neurological disorders. The company primarily focuses on developing therapies for patients with Parkinson's disease, multiple sclerosis, and spinal cord injuries. Acordaes primary business is the development and commercialization of Ampyra (dalfampridine), which is approved in the United States for the improvement of walking in people with multiple sclerosis. This drug works by blocking potassium channels, which leads to an increase in nerve impulse transmission, ultimately improving walking ability in MS patients. Apart from Ampyra, Acorda has a rich pipeline of products that it is developing for the treatment of neurological disorders. The companyes pipeline includes products for the treatment of Parkinsones disease, as well as other products for spinal cord injuries and epilepsy. The company also conducts product research and development activities in partnership with leading academic institutions and biotechnology companies. Acorda has a strong research-focused culture, and the company invests a significant amount of its revenues in R&D. The company has a dedicated team of professionals, including scientists, researchers, and medical specialists, who work tirelessly to bring new products to market. Overall, Acorda Therapeutics Inc is a well-respected and innovative biopharmaceutical company that is dedicated to the development of therapies for neurological disorders. The company's focus on research and development, as well as its strong pipeline of products, makes it one of the leading biopharmaceutical companies in the neuroscience sector.
Company Address: 2 Blue Hill Plaza Pearl River 10965 NY
Company Phone Number: 347-4300 Stock Exchange / Ticker: NASDAQ ACOR
|